|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.340 EUR | -0.37% |
|
+5.53% | -21.93% |
| 03-25 | Hyloris Pharmaceuticals SA Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| 01-20 | Hyloris Pharmaceuticals Partners With Orion to Commercialize Gastric Acid Treatment | MT |
Main competitors
| P/E (Y) | Price to Book (Y) | PEG (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| -12.76x | - | -0.15x | 14.95x | -16.09x | -15.16x | - | 175M | ||
| 29.04x | 17.34x | 0.6x | 10.54x | 21.76x | 22.19x | 0.69% | 906B | ||
| 23.97x | 6.03x | -1.58x | 5.53x | 15.03x | 16.62x | 2.38% | 555B | ||
| 25.34x | -2770.73x | 0.1x | 6.27x | 12.75x | 13.17x | 3.3% | 368B | ||
| 17x | 6.24x | 0.95x | 4.26x | 10.49x | 11.89x | 3.12% | 326B | ||
| 23.38x | 5.42x | 1.09x | 4.85x | 13.78x | 14.48x | 1.8% | 289B | ||
| 20.45x | 6.14x | 40.74x | 5.51x | 13.4x | 14.6x | 3.04% | 285B | ||
| 50.13x | 5.71x | -0.72x | 4.67x | 17.48x | 23.84x | 2.96% | 280B | ||
| 13.42x | 5.82x | -3.29x | 4.92x | 10.04x | 11.82x | 3.76% | 208B | ||
| 21.62x | 15.01x | 2.32x | 5.9x | 10.23x | 13.48x | 3% | 182B | ||
| -48.77x | 8.42x | 0.35x | 5.82x | 32.51x | 65.55x | 2.41% | 165B | ||
| 12.1x | 1.68x | 0.21x | 3.17x | 7.67x | 8.98x | 6.77% | 148B | ||
| 11.06x | 4.9x | 0.23x | 3.04x | 8.13x | 8.85x | 4.45% | 115B | ||
| 25.67x | 4.97x | 1.84x | 7.62x | 17.2x | 17.91x | -.--% | 115B | ||
| 10.71x | 1.18x | 1.51x | 2.15x | 6.96x | 7.56x | 5.85% | 102B | ||
| 11.8x | 4.09x | 0.87x | 2.6x | 7.64x | 8.59x | 3.7% | 102B | ||
| 25.12x | 5.71x | 1.43x | 8.58x | 16.14x | 16.93x | 1.75% | 81.37B | ||
| 39.94x | 5.39x | 2.09x | 9.11x | 30.23x | 34.29x | 0.49% | 54.61B | ||
| 45.99x | 1.15x | 0.71x | 2.67x | 9.86x | 27.95x | 3.87% | 51.96B | ||
| 18.78x | 1.34x | -0.12x | 1.54x | 7.33x | 12.12x | 0.29% | 43.68B | ||
| Average | 18.20x | -140.22x | 2.46x | 5.68x | 12.63x | 16.78x | 2.82% | 218.88B | |
| Weighted average by Cap. | 21.82x | -225.38x | 2.81x | 6.22x | 15.42x | 18.29x | 2.51% |
- Stock Market
- Equities
- HYL Stock
- Sector Hyloris Pharmaceuticals SA
- Sector valuations
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















